Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963).
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 13 (5) , 387-394
- https://doi.org/10.1023/a:1005822920962
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of a new intravenous echo contrast agent (BY 963) with albunex for opacification of left ventricular cavityBasic Research in Cardiology, 1996
- Intravenous albunex during dobutamine stress echocardiography: Enhanced localization of left ventricular endocardial bordersAmerican Heart Journal, 1995
- [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].1995
- Improvement of endocardial border delineation in suboptimal stressechocardiograms using the new left heart contrast agent SH U 508 AThe International Journal of Cardiovascular Imaging, 1994
- Exercise echocardiography for the evaluation of patients after nonsurgical coronary artery revascularizationJournal of the American College of Cardiology, 1993
- Sonicated serum albumin in contrast echocardiography: Improved segmental wall motion depiction and implications for stress echocardiographyThe American Journal of Cardiology, 1992
- Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use.1991
- Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical resultsJournal of the American College of Cardiology, 1990
- ECHOCONTRAST-VENTRICULOGRAPHY - DETERMINATION OF LEFT-VENTRICULAR FUNCTION PARAMETERS BY DIGITAL SUBTRACTION ECHOCARDIOGRAPHY1986
- Ultrasound Cardiography: Contrast Studies in Anatomy and FunctionRadiology, 1969